Want to see JP:7779 full AI Analyst Report?
Top Page
CYBERDYNE
(7779)
Select Model
Select Model
Rating:49Neutral
Price Target:
¥240.00
▲(8.60% Upside)
Action:Reiterated
Date:08/19/26
The score is held back primarily by weak cash flow (negative TTM operating and free cash flow) and a very expensive valuation (P/E ~185). These risks are partially offset by strong recent revenue growth and a very low-leverage balance sheet that provides financial flexibility. Technicals are mixed, with only modest near-term improvement against a weaker longer-term trend.
Positive Factors
Strong Revenue Growth
The sharp TTM revenue increase indicates expanding commercialization and customer adoption of CYBERDYNE’s products. If sustained, greater deployment can improve operating leverage and strengthen the company’s position in medical rehabilitation robotics.
Negative Factors
Negative Operating Cash Flow
Current cash burn means revenue growth is not yet converting into internally generated funding. Continued negative operating and free cash flow could require the company to use its balance sheet or raise capital, limiting the durability of expansion.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Revenue Growth
The sharp TTM revenue increase indicates expanding commercialization and customer adoption of CYBERDYNE’s products. If sustained, greater deployment can improve operating leverage and strengthen the company’s position in medical rehabilitation robotics.
Read all positive factors
CYBERDYNE (7779) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥49.19B
Dividend YieldN/A
Average Volume (3M)724.97K
Price to Earnings (P/E)178.5
Beta (1Y)0.94
Revenue Growth-8.42%
EPS GrowthN/A
CountryJP
Employees203
SectorHealthcare
Sector Strength45
IndustryMedical - Devices
Share Statistics
EPS (TTM)1.30
Shares Outstanding137,445,820
10 Day Avg. Volume764,380
30 Day Avg. Volume724,970
Financial Highlights & Ratios
PEG Ratio-2.89
Price to Book (P/B)1.40
Price to Sales (P/S)14.44
P/FCF Ratio305.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.27
Revenue Forecast (FY)¥4.72B
CYBERDYNE Business Overview & Revenue Model
Company Description
CYBERDYNE, Inc. (7779) is a Japanese medical and robotics company that develops and commercializes wearable robot technology and related cybernics systems, with a primary focus on healthcare and rehabilitation applications. The company’s core offe...
How the Company Makes Money
CYBERDYNE makes money primarily by commercializing its robotic assistive technologies—most notably the HAL exoskeleton—through providing the product and associated usage arrangements to healthcare and care-related customers. Revenue is generated f...
CYBERDYNE Financial Statement Overview
Summary
Income Statement
46
Neutral
Balance Sheet
83
Very Positive
Cash Flow
38
Negative
| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.87B | 3.85B | 4.38B | 4.35B | 3.29B | 2.15B |
| Gross Profit | 1.92B | 2.27B | 2.07B | 2.03B | 1.49B | 1.25B |
| EBITDA | -424.00M | -489.00M | -904.00M | -1.06B | -722.00M | -565.00M |
| Net Income | 276.00M | 153.00M | -577.00M | -1.48B | -298.00M | -498.00M |
Balance Sheet | ||||||
| Total Assets | 49.74B | 49.08B | 48.55B | 50.00B | 50.19B | 49.47B |
| Cash, Cash Equivalents and Short-Term Investments | 13.12B | 8.99B | 6.82B | 5.16B | 7.80B | 20.83B |
| Total Debt | 540.00M | 467.00M | 434.00M | 632.00M | 669.00M | 575.00M |
| Total Liabilities | 9.65B | 9.47B | 8.95B | 9.52B | 8.20B | 6.02B |
| Stockholders Equity | 40.09B | 39.62B | 39.58B | 40.75B | 42.10B | 43.41B |
Cash Flow | ||||||
| Free Cash Flow | -117.00M | 182.00M | -726.00M | -1.07B | -594.00M | -2.33B |
| Operating Cash Flow | -108.00M | 195.00M | -430.00M | -850.00M | -143.00M | -564.00M |
| Investing Cash Flow | 8.20B | 2.09B | 2.33B | -2.08B | 2.17B | -1.79B |
| Financing Cash Flow | -216.00M | -205.00M | -216.00M | 160.00M | 14.00M | 1.25B |
CYBERDYNE Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | ¥10.34B | 16.89 | ― | 3.52% | 5.20% | -17.92% | |
64 Neutral | ¥8.95B | 10.70 | ― | 1.89% | 9.02% | 8.88% | |
63 Neutral | ¥247.96B | 18.01 | ― | 1.92% | 1.43% | 1.86% | |
58 Neutral | ¥191.11B | 21.04 | 0.33% | 3.73% | 3.04% | -19.26% | |
54 Neutral | ¥21.41B | -98.57 | ― | 3.12% | -6.64% | 67.08% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | ¥49.19B | 178.46 | -0.46% | ― | -8.42% | ― |
* Healthcare Sector Average
JP:7779
CYBERDYNE
232.00
25.00
12.08%
JP:6523
PHC Holdings Corp.
1,525.00
561.08
58.21%
JP:5187
Create Medic Co., Ltd.
1,141.00
201.49
21.45%
JP:6849
Nihon Kohden Corporation
1,527.50
-80.14
-4.98%
JP:7600
Japan Medical Dynamic Marketing, Inc.
829.00
320.39
62.99%
JP:7963
Koken Ltd.
1,830.00
66.78
3.79%
CYBERDYNE Corporate Events
CYBERDYNE Posts Higher Q1 Profit but Withholds Full-Year Forecast Amid Market Uncertainty
Aug 13, 2026
CYBERDYNE, Inc. reported consolidated revenue of ¥1,027 million for the three months ended June 30, 2026, a 2.7% year-on-year increase, with profit attributable to owners of the parent rising 49.2% to ¥374 million and basic earnings per ...
CYBERDYNE Boosts SIP Smart Mobility Consignment to ¥194 Million
Jul 29, 2026
CYBERDYNE Inc., a Japanese technology firm listed on the Tokyo Stock Exchange’s Growth Section, specializes in advanced systems and robotics and is an active participant in public-sector innovation projects. Its engagement in national smart ...
CYBERDYNE Boosts SIP Consignment Budget for Human Collaborative Robotics Project
Jul 28, 2026
CYBERDYNE Inc. has revised its business consignment agreement under Japan’s Cross-ministerial Strategic Innovation Promotion Program’s third phase, which targets the development and social implementation of human collaborative robotics...
Cyberdyne Launches Global VC Alliance to Drive Physical AI and Cybernics Growth
Jun 1, 2026
Cyberdyne has formed a strategic business alliance with Silicon Valley-based venture capital firm Pegasus Tech Ventures to accelerate business creation and global expansion in its “HCPS Cybernics with Physical AI” domain. By tapping Pe...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.